首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1383501

2030 年微流體市場預測：按產品、材料、技術、最終用戶和地區分類的全球分析

Microfluidics Market Forecasts to 2030 - Global Analysis By Product (Microfluidics-Based Device, Microfluidics Components and Other Products), Material (Polymer, Metal, Ceramics, Silicon and Glass), Technology, End User and By Geography

出版日期: 2023年11月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據Stratistics MRC預測，2023年全球微流控市場規模將達223億美元，預計2030年將達到593億美元，預測期內年複合成長率為15%。

微流控是一種用於研究流體性質和性質的技術方法。微流體是一種用於研究流體性質和特性的技術方法，其應用包括使用一套工具來操縱和控制小體積流體中的化學和生物過程。它也用於製造包含許多用於流體通過和容納的腔室和隧道的超小型設備。

根據 Globocan 2020 的數據，2020 年全球新增癌症患者人數為 19,282,789 人，預計 2040 年將增加至 28,887,940 人。

技術進步

大規模微流控整合和軟光刻極大地擴展了在醫學和生物科學研究中的應用。這些技術進步加速了研究和開發，使研究人員能夠在更複雜和精密的微流控晶片上進行實驗。此外，微流體組件正迅速成為化學合成、生物感測、生物驅動和醫學等越來越多領域的基本技術。這些因素正在推動市場需求。

高成本

開發和製造流程的高成本極大地阻礙了微流體裝置的廣泛普及。常用的技術包括光刻、軟光刻和微加工，但這些設備的安裝和維護成本昂貴。此外，微流體中使用的材料（例如玻璃和聚合物）可能比其他行業中使用的傳統材料更昂貴。這些因素阻礙了微流體市場的成長。

即時診斷的需求

由於即時診斷需求激增，預計微流體市場在預測期內將實現盈利成長。與其他傳統方法相比，即時診斷可以快速且快速地檢測疾病。它還可以更好地監測、診斷和治療患者，並促進醫療專業人員更快地做出決策。

漫長而複雜的法規過程

醫療設備製造商必須遵守嚴格的法規政策，以確保其器材的安全性和有效性。醫療設備核准流程變得越來越複雜和漫長。一些整合微流體醫療設備核准需要時間才能獲得法規的核准，否則您的投資可能會被浪費。這些因素阻礙了微流控市場的擴張。

COVID-19 的影響

COVID-19 大流行對微流體市場產生了有益的影響。高需求的診斷包括 COVID-19 測試、快速診斷測試以及使用微流體技術進行藥物研發的體外診斷。一些行業相關人員專注於引入基於微流體技術的快速抗原測試來診斷 COVID-19。為了對抗這場流行病，法規還承諾支持批准微流體測試。隨著體外診斷 (IVD) 設備、照護端測試和快速診斷測試的增加，對微流控試劑盒的需求預計也會增加，以確保患者樣本結果的準確性和精密度。不過，預計未來市場將穩定復甦並相對成長。

體外診斷領域預計將在預測期內成為最大的領域。

許多診斷、製藥和生物技術公司以及法醫學應用都使用採用微流體技術的 IVD，例如 PCR 系統、分析儀、PoC 診斷和電泳系統。這些設備具有多種優勢，包括攜帶性、提高測試頻率、減少試劑和樣品消費量以及準確快速的分析。此外，推動基於微流體的概念驗證(PoC) 技術的使用增加的其他重要因素包括廉價消耗品的可用性，以及提供緊湊、整合系統和更快測試結果的 PoC 設備，並且成本可以降低顯著減少。

預計微流控設備產業在預測期間內年複合成長率最高

預計基於微流體的設備領域將在預測期內出現良好的成長。微流體裝置可以顯著增強奈米顆粒和奈米複合材料的合成。原因是微反應器中有效的傳熱和傳質、空間限制、參數調整的便利性以及原位製程監控。許多具有可調尺寸、尺寸分佈和形態的奈米顆粒，包括混合、無機奈米顆粒和型態，已使用微流體裝置成功合成。此外，自動化微型機器人注射、藥物研發和分析以及單細胞捕獲都是微流體裝置的醫學應用。

比最大的地區

由於創新技術的引入、成熟的市場參與者的存在、改進樣本最佳化的選定研究數量的增加以及對 POC 診斷的巨大需求，北美在預測期內佔據了最大的市場佔有率。此外，研究機構繼續在創新微流體設備的開發中發揮主導作用，並有望在可預見的未來保持其在該地區的主導地位。

複合年複合成長率最高的地區：

由於先進的研究基礎設施、經濟成長和勞動力供應，預計亞太地區將在預測期內實現有益成長。此外，亞太地區擁有許多支持微流體技術發展的才華橫溢的科學家、工程師和研究人員。這些專家正在積極致力於開發生物技術、製藥、醫療保健和環境監測等領域的尖端微流體應用。然而，該地區的主要企業正在提出獨特的、具有吸引力的、重點具有成本效益的解決方案，並且有可能在未來年度增加市場佔有率。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

公司簡介
- 其他市場公司的綜合分析（最多 3 家公司）
- 主要企業SWOT分析（最多3家企業）
區域分割
- 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
競爭基準化分析
- 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東/非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東/非洲

第11章進展

合約、夥伴關係、協作和合資企業
收購和合併
新產品發布
業務擴展
其他關鍵策略

第12章公司簡介

Thermofisher
Biomerieux
Quidel Corporation
Illumina Inc
Fluidigm Corporation
Abbott Laboratories
Smc Corporation
Perkinelmer
Idex Corporation
Hologic
Parker-Hannifin Corporation
Becton, Dickinson, and Company
Agilent
Bio-RAD
Hoffmann La-Roche
Danaher Corporation
Fortive Corporation
Aignep SPA
Dolomite Microfluidics
Elveflow

簡介目錄圖表

Product Code: SMRC24349

According to Stratistics MRC, the Global Microfluidics Market is accounted for $22.3 billion in 2023 and is expected to reach $59.3 billion by 2030 growing at a CAGR of 15% during the forecast period. Microfluidics is a technological method used to investigate the nature and characteristics of fluids. Its application involves the manipulation and control of small volumes of fluids' chemical and biological processes through the use of a set of tools. It is also employed in the creation of microminiaturized apparatuses that contain a large number of chambers and tunnels that allow fluids to pass through or be contained.

According to Globocan 2020, there were 19,282,789 new cancer cases worldwide in 2020, with a projected increase to 28,887,940 cases by 2040.

Market Dynamics:

Driver:

Technological advancements

Large-scale microfluidics integration and soft lithography have greatly expanded their applications in medical and biological science research. These technological advancements have accelerated development efforts and allowed researchers to carry out experiments on microfluidics chips with greater complexity and sophistication. Additionally, microfluidics components are quickly becoming an indispensable technology in a growing number of fields, such as chemical synthesis, bio sensing, bio actuation, and medicine. These factors are propelling market demand.

Restraint:

High cost

Widespread adoption of microfluidics devices is severely hampered by the high cost of the development and manufacturing processes. Frequently employed methods include photolithography, soft lithography, and micro-machining, which can be expensive to set up and maintain in terms of equipment. Furthermore, the materials used in microfluidics, like glass or polymers, might be more expensive than conventional materials used in other industries. These factors are hampering the growth of the microfluidics market.

Opportunity:

Demand for point-of-care diagnostics

The microfluidics market is anticipated to exhibit profitable growth potential over the forecast period due to the surge in demand for point-of-care diagnostics. Point-of-care diagnostics offer rapid and quick detection of diseases as compared to other conventional methods. Moreover, better patient monitoring, diagnosis, and treatment results from this and it also facilitate prompt medical decision-making by medical professionals.

Threat:

Time-consuming and complex regulatory process

Manufacturers of medical devices are required to comply with stringent regulatory policies to ensure the safety and efficacy of the devices. The approval process for medical devices has grown increasingly complicated and drawn out. Certain integrated microfluidics medical devices may take a while to receive regulatory approval, and if this is denied, there is a chance that investment will be wasted. These elements are hindering the expansion of the microfluidics market.

COVID-19 Impact

The COVID-19 pandemic had a beneficial effect on the microfluidics market. In-demand diagnostics included COVID-19 testing, rapid diagnostic tests, and IVDs that use microfluidic technology for drug discovery. Several industry participants were focusing on introducing rapid antigen testing based on microfluidics technology to diagnose COVID-19. In an attempt to combat the pandemic, regulatory bodies also promised to support the approval of microfluidics testing. In order to ensure the accuracy and precision of patient sample results, microfluidics kits were predicted to become more in demand as the number of IVD devices, point-of-care testing, and rapid diagnostic tests increased. However, the market is expected to show a steady recovery and relative increase in the future.

The in vitro diagnostics segment is expected to be the largest during the forecast period

The in vitro diagnostics segment is estimated to hold the largest share A growing number of diagnostic, pharmaceutical, and biotechnology companies, as well as forensic applications, are using IVD embedded with microfluidics technologies, such as PCR systems, analyzers, PoC diagnostics, and electrophoretic systems. Multiple advantages are offered by these devices, including portability, increased testing frequency, reduced reagent and sample consumption, and precise and speedy analysis. Moreover, other important factors driving the increased use of microfluidics-based proof-of-concept (PoC) technologies include the availability of inexpensive consumables and the ability of PoC devices to obtain faster test results with compact integrated systems and significantly lower costs.

The microfluidics-based device segment is expected to have the highest CAGR during the forecast period

The microfluidics-based device segment is anticipated to have lucrative growth during the forecast period. The synthesis of nanoparticles and nanocomposites could be greatly enhanced by microfluidics devices because of their effective heat and mass transfers, spatial limitations, ease of parameter adjustment, and in situ process monitoring in micro reactors. Many nanoparticles with tunable sizes, size distributions, and morphologies, including hybrid, inorganic, and organic ones, have been successfully synthesized using microfluidics devices. Moreover, automated micro-robotic injection, drug discovery and analysis, and single-cell trapping are among the biomedical uses of microfluidics devices.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the introduction of innovative technologies, the presence of well-established market players, the rise in the number of studies chosen to improve sample optimization, and the substantial demand for POC diagnostics. Furthermore, it is anticipated that research institutes will continue to play a leading role in the development of innovative microfluidics devices, maintaining their dominance in the region for the foreseeable future.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the advanced infrastructure for research, the growing economy, and the accessibility of labor. Furthermore, a sizable pool of highly qualified scientists, engineers, and researchers who support the development of microfluidics technologies reside in the Asia Pacific region. These experts are actively engaged in creating cutting-edge microfluidics applications in fields like biotechnology, pharmaceuticals, healthcare, and environmental monitoring. However, prominent players in the region are putting forth creative and intriguing performance- and, more importantly, cost-effective solutions, which may enable them to increase their market share in the years to come.

Key players in the market

Some of the key players in the Microfluidics Market include: Thermofisher, Biomerieux, Quidel Corporation, Illumina Inc, Fluidigm Corporation, Abbott Laboratories, Smc Corporation, Perkinelmer, Idex Corporation, Hologic, Parker-Hannifin Corporation, Becton, Dickinson, and Company, Agilent, Bio-RAD, Hoffmann La-Roche, Danaher Corporation, Fortive Corporation, Aignep S.P.A, Dolomite Microfluidics and Elveflow.

Key Developments:

In July 2021, Abbott launched the Panbio COVID-19 Antigen Self-Test in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

In June 2021, Danaher's Life science segment acquired Precision Nanosystems (PNI) to complement the former vaccines and therapeutics development business.

In February 2021, Thermo fisher acquired the point-of-care molecular diagnostic company Mesa Biotech, Inc. This is expected to raise Thermo fisher's revenue by approximately USD 200 million.

Products Covered:

Microfluidics-Based Device
Microfluidics Components
Other Products

Materials Covered:

Polymer
Metal
Ceramics
Silicon
Glass

Technologies Covered:

Pharmaceutical & Life Science Research and Manufacturing
In Vitro Diagnostics
Therapeutics

End Users Covered:

Academic and Research Institutes
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Microfluidics Market, By Product

5.1 Introduction
5.2 Microfluidics-Based Device
5.3 Microfluidic Components
- 5.3.1 Flow and Pressure Sensors
- 5.3.2 Microfluidic Chip
- 5.3.3 Micropumps
- 5.3.4 Flow and Pressure Controllers
- 5.3.5 Microneedles
- 5.3.6 Microfluidic Valves
5.4 Other Products

6 Global Microfluidics Market, By Material

6.1 Introduction
6.2 Polymer
- 6.2.1 Non-polyvinyl Chloride
- 6.2.2 Polyvinyl Chloride
6.3 Metal
6.4 Ceramics
6.5 Silicon
6.6 Glass

7 Global Microfluidics Market, By Technology

7.1 Introduction
7.2 Non-Medical
7.3 Medical

8 Global Microfluidics Market, By Application

8.1 Introduction
8.2 Pharmaceutical & Life Science Research and Manufacturing
- 8.2.1 Lab Analytics
  - 8.2.1.1 Cell-Based Assays
  - 8.2.1.2 Proteomic Analysis
  - 8.2.1.3 Capillary Electrophoresis
  - 8.2.1.4 Genomic Analysis
- 8.2.2 Microdispensing
- 8.2.3 Microreaction
8.3 In Vitro Diagnostics
- 8.3.1 Point Of Care Testing
- 8.3.2 Clinical Diagnostics
- 8.3.3 Veterinary Diagnostics
8.4 Therapeutics
- 8.4.1 Wearable Devices
- 8.4.2 Drug Delivery

9 Global Microfluidics Market, By End User

9.1 Introduction
9.2 Academic and Research Institutes
9.3 Hospitals and Diagnostic Centers
9.4 Pharmaceutical and Biotechnology Companies

10 Global Microfluidics Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Thermofisher
12.2 Biomerieux
12.3 Quidel Corporation
12.4 Illumina Inc
12.5 Fluidigm Corporation
12.6 Abbott Laboratories
12.7 Smc Corporation
12.8 Perkinelmer
12.9 Idex Corporation
12.10 Hologic
12.11 Parker-Hannifin Corporation
12.12 Becton, Dickinson, and Company
12.13 Agilent
12.14 Bio-RAD
12.15 Hoffmann La-Roche
12.16 Danaher Corporation
12.17 Fortive Corporation
12.18 Aignep S.P.A
12.19 Dolomite Microfluidics
12.20 Elveflow

簡介目錄圖表

List of Tables

Table 1 Global Microfluidics Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Microfluidics Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Microfluidics Market Outlook, By Microfluidics-Based Device (2021-2030) ($MN)
Table 4 Global Microfluidics Market Outlook, By Microfluidic Components (2021-2030) ($MN)
Table 5 Global Microfluidics Market Outlook, By Flow and Pressure Sensors (2021-2030) ($MN)
Table 6 Global Microfluidics Market Outlook, By Microfluidic Chip (2021-2030) ($MN)
Table 7 Global Microfluidics Market Outlook, By Micropumps (2021-2030) ($MN)
Table 8 Global Microfluidics Market Outlook, By Flow and Pressure Controllers (2021-2030) ($MN)
Table 9 Global Microfluidics Market Outlook, By Microneedles (2021-2030) ($MN)
Table 10 Global Microfluidics Market Outlook, By Microfluidic Valves (2021-2030) ($MN)
Table 11 Global Microfluidics Market Outlook, By Other Products (2021-2030) ($MN)
Table 12 Global Microfluidics Market Outlook, By Material (2021-2030) ($MN)
Table 13 Global Microfluidics Market Outlook, By Polymer (2021-2030) ($MN)
Table 14 Global Microfluidics Market Outlook, By Non-polyvinyl Chloride (2021-2030) ($MN)
Table 15 Global Microfluidics Market Outlook, By Polyvinyl Chloride (2021-2030) ($MN)
Table 16 Global Microfluidics Market Outlook, By Metal (2021-2030) ($MN)
Table 17 Global Microfluidics Market Outlook, By Ceramics (2021-2030) ($MN)
Table 18 Global Microfluidics Market Outlook, By Silicon (2021-2030) ($MN)
Table 19 Global Microfluidics Market Outlook, By Glass (2021-2030) ($MN)
Table 20 Global Microfluidics Market Outlook, By Technology (2021-2030) ($MN)
Table 21 Global Microfluidics Market Outlook, By Non-Medical (2021-2030) ($MN)
Table 22 Global Microfluidics Market Outlook, By Medical (2021-2030) ($MN)
Table 23 Global Microfluidics Market Outlook, By Application (2021-2030) ($MN)
Table 24 Global Microfluidics Market Outlook, By Pharmaceutical & Life Science Research and Manufacturing (2021-2030) ($MN)
Table 25 Global Microfluidics Market Outlook, By Lab Analytics (2021-2030) ($MN)
Table 26 Global Microfluidics Market Outlook, By Microdispensing (2021-2030) ($MN)
Table 27 Global Microfluidics Market Outlook, By Microreaction (2021-2030) ($MN)
Table 28 Global Microfluidics Market Outlook, By In Vitro Diagnostics (2021-2030) ($MN)
Table 29 Global Microfluidics Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
Table 30 Global Microfluidics Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
Table 31 Global Microfluidics Market Outlook, By Veterinary Diagnostics (2021-2030) ($MN)
Table 32 Global Microfluidics Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 33 Global Microfluidics Market Outlook, By Wearable Devices (2021-2030) ($MN)
Table 34 Global Microfluidics Market Outlook, By Drug Delivery (2021-2030) ($MN)
Table 35 Global Microfluidics Market Outlook, By End User (2021-2030) ($MN)
Table 36 Global Microfluidics Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 37 Global Microfluidics Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
Table 38 Global Microfluidics Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)